Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Maykel Farag Ghabrash, Arash Bahremand, Martine Veilleux, Geneviève Blais-Normandin, Gabrielle Chicoine, Catherine Sutra-Cole, Navdeep Kaur, Daniela Ziegler, Simon Dubreucq, Louis-Christophe Juteau, Laurent Lestage & Didier Jutras-Aswad. (2020) Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. Journal of Dual Diagnosis 16:2, pages 191-207.
Read now
Read now
John M Zajecka, Arielle D Stanford, Asli Memisoglu, William F Martin & Sanjeev Pathak. (2019) Buprenorphine/samidorphan combination for the adjunctive treatment of major depressive disorder: results of a phase III clinical trial (FORWARD-3). Neuropsychiatric Disease and Treatment 15, pages 795-808.
Read now
Read now
Renee-Marie Ragguett, Carola Rong, Joshua D. Rosenblat, Roger C. Ho & Roger S. McIntyre. (2018) Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder. Expert Opinion on Drug Metabolism & Toxicology 14:4, pages 475-482.
Read now
Read now
Maurice Dematteis, Marc Auriacombe, Oscar D’Agnone, Lorenzo Somaini, Néstor Szerman, Richard Littlewood, Farrukh Alam, Hannu Alho, Amine Benyamina, Julio Bobes, Jean Pierre Daulouede, Claudio Leonardi, Icro Maremmani, Marta Torrens, Stephan Walcher & Michael Soyka. (2017) Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy 18:18, pages 1987-1999.
Read now
Read now
Jaak Panksepp. (2015) Affective preclinical modeling of psychiatric disorders: taking imbalanced primal emotional feelings of animals seriously in our search for novel antidepressants. Dialogues in Clinical Neuroscience 17:4, pages 363-379.
Read now
Read now
Mark Collen. (2015) Operationalizing Pain Treatment in the Biopsychosocial Model: Take a Daily “SWEM”—Socialize, Work, Exercise, Meditate. Journal of Pain & Palliative Care Pharmacotherapy 29:3, pages 290-299.
Read now
Read now
Angelo Giovanni Icro Maremmani, Fabio Rugani, Silvia Bacciardi, Luca Rovai, Enrico Massimetti, Denise Gazzarrini, Liliana Dell’Osso & Icro Maremmani. (2015) Differentiating Between the Course of Illness in Bipolar 1 and Chronic-Psychotic Heroin-Dependent Patients at Their First Agonist Opioid Treatment. Journal of Addictive Diseases 34:1, pages 43-54.
Read now
Read now
David Potik, Einat Peles, Yahli Abramsohn, Miriam Adelson & Shaul Schreiber. (2014) The Relationship Between Vulnerable Attachment Style, Psychopathology, Drug Abuse, and Retention in Treatment Among Methadone Maintenance Treatment Patients. Journal of Psychoactive Drugs 46:4, pages 325-333.
Read now
Read now
Articles from other publishers (89)
Hadiya Kar, Abdul Majid Gania, Altaf Bandy, Nizam ud din Dar & Farhana Rafiq. (2023) Psychiatric comorbidities and concurrent substance use among people who inject drugs: a single-centre hospital-based study. Scientific Reports 13:1.
Crossref
Crossref
Gabriel Bastien, Christina McAnulty, Omar Ledjiar, M. Eugenia Socias, Bernard Le Foll, Ron Lim, Ahmed N. Hassan, Suzanne Brissette, Stéphanie Marsan, Annie Talbot & Didier Jutras-Aswad. (2022) Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial. The Canadian Journal of Psychiatry 68:8, pages 572-585.
Crossref
Crossref
Shaul Schreiber, Lee Keidan & Chaim G. Pick. (2023) Treatment-Resistant Depression (TRD): Is the Opioid System Involved?. International Journal of Molecular Sciences 24:13, pages 11142.
Crossref
Crossref
Lucja Szumiec, Ryszard Bugno, Lukasz Szumiec & Ryszard Przewlocki. (2023) The differential influence of PZM21, a nonrewarding μ-opioid receptor agonist with G protein bias, on behavioural despair and fear response in mice. Behavioural Brain Research 449, pages 114466.
Crossref
Crossref
Samantha Colledge-Frisby, Nicola Jones, Louisa Degenhardt, Matthew Hickman, Prianka Padmanathan, Thomas SantoJrJr, Michael Farrell & Natasa Gisev. (2023) Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study. Drug and Alcohol Dependence 246, pages 109851.
Crossref
Crossref
Melissa E. Milanak, Sara M. Witcraft, Jie Young Park, Katharine Hassell, Tierney McMahon & Allison K. Wilkerson. (2023) A Transdiagnostic group therapy for sleep and anxiety among adults with substance use disorders: Protocol and pilot investigation. Frontiers in Psychiatry 14.
Crossref
Crossref
Astrid M. Cardona-Acosta & Carlos A. Bolaños-Guzmán. (2023) Role of the mesolimbic dopamine pathway in the antidepressant effects of ketamine. Neuropharmacology 225, pages 109374.
Crossref
Crossref
Marcelina Jasmine Silva, Zhanette Coffee, Chong Ho Alex Yu & Joshua Hu. (2023) Changes in Psychological Outcomes after Cessation of Full Mu Agonist Long-Term Opioid Therapy for Chronic Pain. Journal of Clinical Medicine 12:4, pages 1354.
Crossref
Crossref
David C. Currow & Diana H. Ferreira. 2023. Evidence-Based Practice of Palliative Medicine. Evidence-Based Practice of Palliative Medicine
121
130
.
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
109
163
.
Luke A. Jelen, Allan H. Young & Mitul A. Mehta. 2023.
Hamid Jomehpour, Mohammad Amin Pouriran, Aazam Sadat Heydari Yazdi, Mehri Baghban Haghighi, Masume Sadat Dastgheib, Sahar Omidvar-Tehrani & Ali Talaei. (2022) Comparison of Psychopathologic Characteristics between Individuals Undergoing Methadone Maintenance Treatment, Opioid Dependents, and Control Group. Addiction and Health 14:4, pages 256-262.
Crossref
Crossref
Luke A. Jelen, James M. Stone, Allan H. Young & Mitul A. Mehta. (2022) The opioid system in depression. Neuroscience & Biobehavioral Reviews 140, pages 104800.
Crossref
Crossref
Luigi Grillo. (2022) A possible anti-anxiety effect of appetitive aggression and a possible link to the work of Donald Winnicott. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology 10:1, pages 102-113.
Crossref
Crossref
Jaena Han, Valentine Andreu, Cory Langreck, Elizabeth A. Pekarskaya, Steven G. Grinnell, Florence Allain, Valerie Magalong, John Pintar, Brigitte L. Kieffer, Alexander Z. Harris, Jonathan A. Javitch, René Hen & Katherine M. Nautiyal. (2021) Mu opioid receptors on hippocampal GABAergic interneurons are critical for the antidepressant effects of tianeptine. Neuropsychopharmacology 47:7, pages 1387-1397.
Crossref
Crossref
Evan M. Hess, Lace M. Riggs, Michael Michaelides & Todd D. Gould. (2022) Mechanisms of ketamine and its metabolites as antidepressants. Biochemical Pharmacology 197, pages 114892.
Crossref
Crossref
Abby L. Cheng, Brian K. Brady, Ethan C. Bradley, Ryan P. Calfee, Lisa M. Klesges, Graham A. Colditz & Heidi Prather. (2021) Opioid use and social disadvantage in patients with chronic musculoskeletal pain. PM&R 14:3, pages 309-319.
Crossref
Crossref
Amanda B. Namchuk, Irwin Lucki & Caroline A. Browne. (2022) Buprenorphine as a Treatment for Major Depression and Opioid Use Disorder. Advances in Drug and Alcohol Research 2.
Crossref
Crossref
Charles B. Nemeroff. (2022) Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression. American Journal of Psychiatry 179:2, pages 83-84.
Crossref
Crossref
Yih‐Ing Hser, Yuhui Zhu, Zhe Fei, Larissa J. Mooney, Elizabeth A. Evans, Annemarie Kelleghan, Abigail Matthews, Caroline Yoo & Andrew J. Saxon. (2021) Long‐term follow‐up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. Addiction 117:1, pages 151-161.
Crossref
Crossref
Vasantha K. Kumar. 2022. Handbook on Opium. Handbook on Opium
157
177
.
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry
451
536
.
Eli Magen, Akim Geishin & Ari Lauden. (2021) Rapid Improvement of Treatment-Resistant Major Depression During the Administration of Low-Dose Oxycodone. Journal of Clinical Psychopharmacology 41:1, pages 81-83.
Crossref
Crossref
Pablo Carrillo, Anne-Cécile Petit, Raphaël Gaillard & Fabien Vinckier. (2020) The next psychoactive drugs: From imipramine to ketamine. Bulletin de l'Académie Nationale de Médecine 204:9, pages e169-e177.
Crossref
Crossref
P. Carrillo, A.-C. Petit, R. Gaillard & F. Vinckier. (2020) Psychotropes du futur : de l’imipramine à la kétamine. Bulletin de l'Académie Nationale de Médecine 204:9, pages 1034-1042.
Crossref
Crossref
Sao Mai Le, Philippe Trouiller, Huong Duong Thi, Oanh Khuat Thi Hai, Khue Pham Minh, Roselyne Vallo, Delphine Rapoud, Catherine Quillet, Thuy Linh Nguyen, Quang Duc Nguyen, Tuyet Thanh NhamThi, Giang Hoang Thi, Jonathan Feelemyer, Vinh Vu Hai, Jean-Pierre Moles, Hong Quang Doan, Didier Laureillard, Don C. Des Jarlais, Nicolas Nagot & Laurent Michel. (2020) Daily heroin injection and psychiatric disorders: A cross-sectional survey among People Who Inject Drugs (PWID) in Haiphong, Vietnam. Drug and Alcohol Dependence 216, pages 108334.
Crossref
Crossref
Bardia Varastehmoradi, Gregers Wegener, Connie Sanchez & Karen L. Smith. (2020) Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders. Behavioural Pharmacology 31:2&3, pages 122-135.
Crossref
Crossref
Matthew E. Klein, Joshua Chandra, Salma Sheriff & Roberto Malinow. (2020) Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents. Proceedings of the National Academy of Sciences 117:5, pages 2656-2662.
Crossref
Crossref
Rebecca M Skadberg, Todd M Moore & L Christian Elledge. (2020) A 20-year study of the bidirectional relationship between anxious and depressive symptomology and pain medication usage. Pain Management 10:1, pages 13-22.
Crossref
Crossref
Corey B. Puryear, Julie Brooks, Laura Tan, Karen Smith, Yan Li, Jacobi Cunningham, Mark S. Todtenkopf, Reginald L. Dean & Connie Sanchez. (2020) Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data?. Neuroscience & Biobehavioral Reviews 108, pages 658-678.
Crossref
Crossref
Anuj Gupta. 2020. Psychopharmacology in British Literature and Culture, 1780–1900. Psychopharmacology in British Literature and Culture, 1780–1900
155
170
.
Benedicte Nobile, Pierre-Eric Lutz, Emilie Olie & Philippe Courtet. 2020. Behavioral Neurobiology of Suicide and Self Harm. Behavioral Neurobiology of Suicide and Self Harm
197
210
.
James Kessler, Diane Dawley, Daniel Crow, Ramin Garmany & Philippe Georgel. (2019) Potential Health Risks Linked to Emerging Contaminants in Major Rivers and Treated Waters. Water 11:12, pages 2615.
Crossref
Crossref
Michael E. Thase, Arielle D. Stanford, Asli Memisoglu, William Martin, Amy Claxton, J. Alexander Bodkin, Madhukar H. Trivedi, Maurizio Fava, Miao Yu & Sanjeev Pathak. (2019) Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder. Neuropsychopharmacology 44:13, pages 2268-2276.
Crossref
Crossref
Renee-Marie Ragguett, Jocelyn K. Tamura & Roger S. McIntyre. (2019) Keeping up with the clinical advances: depression. CNS Spectrums 24:S1, pages 25-37.
Crossref
Crossref
Mireia Carcolé, Daniel Zamanillo, Manuel Merlos, Begoña Fernández-Pastor, David Cabañero & Rafael Maldonado. (2019) Blockade of the Sigma-1 Receptor Relieves Cognitive and Emotional Impairments Associated to Chronic Osteoarthritis Pain. Frontiers in Pharmacology 10.
Crossref
Crossref
Kellen Rosa da Cruz, Danielle Ianzer, Larissa Córdova Turones, Lilian Liz Reis, Gabriel Camargo-Silva, Michelle Mendanha Mendonça, Elder Sales da Silva, Gustavo Rodrigues Pedrino, Carlos Henrique de Castro, Elson Alves Costa & Carlos H. Xavier. (2019) Behavioral effects evoked by the beta globin-derived nonapeptide LVV-H6. Peptides 115, pages 59-68.
Crossref
Crossref
Marta Peciña, Jordan F. Karp, Sanjay Mathew, Mark S. Todtenkopf, Elliot W. Ehrich & Jon-Kar Zubieta. (2018) Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches. Molecular Psychiatry 24:4, pages 576-587.
Crossref
Crossref
Deepika Anand, Catherine Paquette, Anna Bartuska & Stacey B. Daughters. (2019) Substance type moderates the longitudinal association between depression and substance use from pre-treatment through a 1-year follow-up. Drug and Alcohol Dependence 197, pages 87-94.
Crossref
Crossref
Nikita N. Burke, Mehnaz Ferdousi, Daniel R. Deaver, David P. Finn, Michelle Roche & John P. Kelly. (2019) Locomotor and anti-immobility effects of buprenorphine in combination with the opioid receptor modulator samidorphan in rats. Neuropharmacology 146, pages 327-336.
Crossref
Crossref
Karen L. Smith, Jacobi I. Cunningham, David J. Eyerman, Reginald L. DeanIIIIII, Daniel R. Deaver & Connie Sanchez. (2019) Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat. Neuropharmacology 146, pages 316-326.
Crossref
Crossref
Mervin Chávez-Castillo, Victoria Núñez, Manuel Nava, Ángel Ortega, Milagros Rojas, Valmore Bermúdez & Joselyn Rojas-Quintero. (2019) Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines. Advances in Pharmacological Sciences 2019, pages 1-20.
Crossref
Crossref
J.I. Cunningham, N.N. Burke, M.S. Todtenkopf, D.P. Finn, M. Roche, J.P. Kelly, D.J. Eyerman & C. Sanchez. (2019) Samidorphan attenuates the effects of buprenorphine in rat models evaluating abuse potential. European Neuropsychopharmacology 29, pages S344.
Crossref
Crossref
Max A. Lazar & Roger S. McIntyre. 2019. Neurobiology of Depression. Neurobiology of Depression
383
400
.
Parnika P. Saxena & J. Alexander Bodkin. (2018) Opioidergic Agents as Antidepressants: Rationale and Promise. CNS Drugs 33:1, pages 9-16.
Crossref
Crossref
Gianluca Serafini, Giulia Adavastro, Giovanna Canepa, Domenico De Berardis, Alessandro Valchera, Maurizio Pompili, Henry Nasrallah & Mario Amore. (2018) The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review. International Journal of Molecular Sciences 19:8, pages 2410.
Crossref
Crossref
Alyssa M. Peckham, Austin De La Cruz & Robert L. Dufresne. (2018) Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?. Mental Health Clinician 8:4, pages 175-183.
Crossref
Crossref
Erin Kelty & Gary Hulse. (2017) Self-Injuring Behavior and Mental Illness in Opioid-Dependent Patients Treated with Implant Naltrexone, Methadone, and Buprenorphine in Western Australia. International Journal of Mental Health and Addiction 16:1, pages 187-198.
Crossref
Crossref
Kelly L. McHugh & John P. Kelly. 2018. The Opioid System as the Interface between the Brain’s Cognitive and Motivational Systems. The Opioid System as the Interface between the Brain’s Cognitive and Motivational Systems
49
87
.
Hélène PeyrièreCaroline DiotErika NogueMarie VerschaveMorgan LaureMarie-Christine PicotPierre PetitHélène Donnadieu-RigoleYves Leglise. (2017) Prevalence of Antipsychotic-Treated Patients in a Cohort of Adult Addicted Patients. Journal of Clinical Psychopharmacology 37:6, pages 669-674.
Crossref
Crossref
Christina S. Lee, Jane M. Liebschutz, Bradley J. Anderson & Michael D. Stein. (2017) Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge. The American Journal on Addictions 26:7, pages 667-672.
Crossref
Crossref
Ahmed N. Hassan, Aaron S. Howe, Andriy V. Samokhvalov, Bernard Le Foll & Tony P. George. (2017) Management of mood and anxiety disorders in patients receiving opioid agonist therapy: Review and meta-analysis. The American Journal on Addictions 26:6, pages 551-563.
Crossref
Crossref
Cornel N. Stanciu, Oliver M. Glass & Thomas M. Penders. (2017) Use of Buprenorphine in treatment of refractory depression—A review of current literature. Asian Journal of Psychiatry 26, pages 94-98.
Crossref
Crossref
Jiyao Sheng, Shui Liu, Yicun Wang, Ranji Cui & Xuewen Zhang. (2017) The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plasticity 2017, pages 1-10.
Crossref
Crossref
Ryszard Przewlocki & Osborne F.X. Almeida. 2017. Hormones, Brain and Behavior. Hormones, Brain and Behavior
225
260
.
Laurence Lalanne, Pierre-Eric Lutz, Benoit Trojak, Jean-Philippe Lang, Brigitte L. Kieffer & Elisabeth Bacon. (2016) Medications between psychiatric and addictive disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 65, pages 215-223.
Crossref
Crossref
Luigi Grillo. (2016) A Possible Role of Anhedonia as Common Substrate for Depression and Anxiety. Depression Research and Treatment 2016, pages 1-8.
Crossref
Crossref
Mirko Manchia, Martina Pinna & Eileen M. Denovan-Wright. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
111
119
.
Emmanuel Darcq, Paul Chu-Sin-Chung, Brigitte L. Kieffer & Pierre-Eric Lutz. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
631
653
.
Jonathan C. Fellers. 2016. Treating Comorbid Opioid Use Disorder in Chronic Pain. Treating Comorbid Opioid Use Disorder in Chronic Pain
3
12
.
Jaak Panksepp. 2017. Social Behavior from Rodents to Humans. Social Behavior from Rodents to Humans
109
125
.
Alan F. Schatzberg. (2015) Development of New Psychopharmacological Agents for Depression and Anxiety. Psychiatric Clinics of North America 38:3, pages 379-393.
Crossref
Crossref
Elliot Ehrich, Ryan Turncliff, Yangchun Du, Richard Leigh-Pemberton, Emilio Fernandez, Reese Jones & Maurizio Fava. (2014) Evaluation of Opioid Modulation in Major Depressive Disorder. Neuropsychopharmacology 40:6, pages 1448-1455.
Crossref
Crossref
Edgardo Falcon, Kaitlyn Maier, Shivon A. Robinson, Tiffany E. Hill-Smith & Irwin Lucki. (2014) Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology 232:5, pages 907-915.
Crossref
Crossref
Mika Naganawa, Ming-Qiang Zheng, Shannan Henry, Nabeel Nabulsi, Shu-Fei Lin, Jim Ropchan, David Labaree, Soheila Najafzadeh, Michael Kapinos, Johannes Tauscher, Alexander Neumeister, Richard E. Carson & Yiyun Huang. (2015)
Test–Retest Reproducibility of Binding Parameters in Humans with
11
C-LY2795050, an Antagonist PET Radiotracer for the κ Opioid Receptor
. Journal of Nuclear Medicine 56:2, pages 243-248.
Crossref
Crossref
Mika Naganawa, Leslie K. Jacobsen, Ming-Qiang Zheng, Shu-Fei Lin, Anindita Banerjee, Wonkyung Byon, David Weinzimmer, Giampaolo Tomasi, Nabeel Nabulsi, Sarah Grimwood, Lori L. Badura, Richard E. Carson, Timothy J. McCarthy & Yiyun Huang. (2014) Evaluation of the agonist PET radioligand [11C]GR103545 to image kappa opioid receptor in humans: Kinetic model selection, test–retest reproducibility and receptor occupancy by the antagonist PF-04455242. NeuroImage 99, pages 69-79.
Crossref
Crossref
Jaak Panksepp, Jason S. Wright, Máté D. Döbrössy, Thomas E. Schlaepfer & Volker A. Coenen. (2014) Affective Neuroscience Strategies for Understanding and Treating Depression. Clinical Psychological Science 2:4, pages 472-494.
Crossref
Crossref
Gary Reid, Mukta Sharma & Peter Higgs. (2014) The Long Winding Road of Opioid Substitution Therapy Implementation in South-East Asia: Challenges to Scale Up. Journal of Public Health Research 3:1, pages jphr.2014.204.
Crossref
Crossref
Catherine Q. Howe & Mark D. Sullivan. (2014) The missing ‘P’ in pain management: how the current opioid epidemic highlights the need for psychiatric services in chronic pain care. General Hospital Psychiatry 36:1, pages 99-104.
Crossref
Crossref
Peter Roy-Byrne, Mark D. Sullivan, Cathy D. Sherbourne, Daniela Golinelli, Michelle G. Craske, Greer Sullivan & Murray B. Stein. (2013) Effects of Pain and Prescription Opioid Use on Outcomes in a Collaborative Care Intervention for Anxiety. The Clinical Journal of Pain 29:9, pages 800-806.
Crossref
Crossref
Mohammad Nasehi, Faezeh Kafi & Mohammad-Reza Zarrindast. (2013) Differential mechanisms of opioidergic and dopaminergic systems of the ventral hippocampus (CA3) in anxiolytic-like behaviors induced by cholestasis in mice. European Journal of Pharmacology 714:1-3, pages 352-358.
Crossref
Crossref
Dragana Ivkovich Claflin, Patricia A. Schiml, Nadia Kardegar, Jennifer Caudill, Riaun Floyd, Terrence Deak, Jaak Panksepp & Michael B. Hennessy. (2013) Responses of guinea pigs to brain stimulation during isolation: Examining the transition from “protest” to depressive-like behavior. Neurology, Psychiatry and Brain Research 19:2, pages 67-75.
Crossref
Crossref
M. V. Ovsyukova, T. A. Obut & S. K. Saryg. (2013) Effects of Dehydroepiandrosterone Sulfate on Anxiety and Depressive Behavior: Involvement of μ-Opioid Receptors. Neuroscience and Behavioral Physiology 43:4, pages 505-511.
Crossref
Crossref
Angelo Giovanni Icro Maremmani, Silvia Bacciardi, Luca Rovai, Fabio Rugani, Liliana Dell’Osso & Icro Maremmani. (2013) Natural History of Addiction in Psychotic Heroin-addicted Patients at Their First Agonist Opioid Treatment. Addictive Disorders & Their Treatment 12:1, pages 31-39.
Crossref
Crossref
Pierre-Eric Lutz & Brigitte L. Kieffer. (2013) Opioid receptors: distinct roles in mood disorders. Trends in Neurosciences 36:3, pages 195-206.
Crossref
Crossref
Amy P. Abernethy, Arif Kamal, Jennifer M. Maguire & David C. Currow. 2013. Evidence-Based Practice in Palliative Medicine. Evidence-Based Practice in Palliative Medicine
103
110
.
Catherine Q. Howe, Mark D. Sullivan, Kathleen W. Saunders, Joseph O. Merrill, Caleb J. Banta-Green, Constance Weisner, Cynthia I. Campbell & Michael Von Korff. (2012) Depression and Ambivalence Toward Chronic Opioid Therapy for Chronic Noncancer Pain. The Clinical Journal of Pain 28:7, pages 561-566.
Crossref
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Crossref
Alexandre J. Parent, Nicolas Beaudet, Hélène Beaudry, Jenny Bergeron, Patrick Bérubé, Guy Drolet, Philippe Sarret & Louis Gendron. (2012) Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behavioural Brain Research 229:1, pages 160-167.
Crossref
Crossref
Arif H. KamalJennifer M. MaguireJane L. WheelerDavid C. CurrowAmy P. Abernethy. (2012) Dyspnea Review for the Palliative Care Professional: Treatment Goals and Therapeutic Options. Journal of Palliative Medicine 15:1, pages 106-114.
Crossref
Crossref
Larry Normansell & Jaak Panksepp. (2011) Glutamatergic modulation of separation distress: Profound emotional effects of excitatory amino acids in chicks. Neuroscience & Biobehavioral Reviews 35:9, pages 1890-1901.
Crossref
Crossref
Margaret R. Zellner, Douglas F. Watt, Mark Solms & Jaak Panksepp. (2011) Affective neuroscientific and neuropsychoanalytic approaches to two intractable psychiatric problems: Why depression feels so bad and what addicts really want. Neuroscience & Biobehavioral Reviews 35:9, pages 2000-2008.
Crossref
Crossref
Francisco González-Saiz, Óscar M. Lozano Rojas, Juana Martín Esteban, Izaskun Bilbao Acedos, Rosario Ballesta Gómez & Josefa Gutiérrez Ortega. (2011) Comorbilidad psiquiátrica en una muestra de pacientes con dependencia de opiáceos tratados con buprenorfina sublingual en régimen de comunidad terapéutica. Revista de Psiquiatría y Salud Mental 4:2, pages 81-87.
Crossref
Crossref
Karen Wager-Smith & Athina Markou. (2011) Depression: A repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neuroscience & Biobehavioral Reviews 35:3, pages 742-764.
Crossref
Crossref
Francisco González-Saiz, Óscar M. Lozano Rojas, Juana Martín Esteban, Izaskun Bilbao Acedos, Rosario Ballesta Gómez & Josefa Gutiérrez Ortega. (2011) Psychiatric comorbidity in a sample of opiate-dependent patients treated with sublingual buprenorphine in a therapeutic community regime. Revista de Psiquiatría y Salud Mental (English Edition) 4:2, pages 81-87.
Crossref
Crossref
Michael A. Ansonoff, Ting Wen & John E. Pintar. 2011. The Opiate Receptors. The Opiate Receptors
341
388
.
Melinda Campopiano. (2010) Methadone maintenance therapy in the United States: a case example of dual diagnosis. Advances in Dual Diagnosis 3:3, pages 11-16.
Crossref
Crossref
Colleen Loo, Brett Simpson & Ross MacPherson. (2010) Augmentation Strategies in Electroconvulsive Therapy. The Journal of ECT 26:3, pages 202-207.
Crossref
Crossref
Michael D. Stein, Debra S. Herman, Malyna Kettavong, Patricia A. Cioe, Peter D. Friedmann, Tahir Tellioglu & Bradley J. Anderson. (2010) Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. Journal of Substance Abuse Treatment 39:2, pages 157-166.
Crossref
Crossref